index  
coursenewsroomcompanycontactlogin
 
Product Description and Benefits
  Indications for Use
  Product Makeup/Histology
  Clinical Sequence
 
    Venous Stasis Ulceration
    Ulceration to both feet and anterior ankles
    Trans-metatarsal amputation
    Traumatic degloving calcaneal fracture
    Stump Salvage
    Achilles Ulcer
    Exposed Bone
    Chronic Venous Ulceration
    Immunopathic Wound
    Exposed Joint
    Limb Salvage
    Leg Ulceration
    Arterial Disease
    Hypercoagulable Disorder
    Ankle Ulcer
    Ischemic Ulceration
    Forefoot Ulceration
    Heel Ulcer
 
  Summary
   

Case Studies - Section Summary
Previous | Next Next

In this section, you have learned:

  • INTEGRA™ Bilayer Matrix Wound Dressing can be used in a variety of chronic and traumatic applications
  • The wound is surgically debrided or excised to viable tissue and INTEGRA™ Bilayer Matrix Wound Dressing is applied. Over the next 2-4 weeks, the matrix is remodeled as the patient's cells rebuild the damaged site while simultaneously degrading the collagen-GAG matrix. After the remodeled wound has developed, the silicone layer is removed and complete wound closure occurs as epidermal cells migrate from the wound edges. For larger wounds, a thin epidermal autograft 0.004-0.006 inches (0.1016 - 0.1524 millimeters) may be applied. As shown, wound closure is typically complete in about 30 days.

To continue your review of the COURSE, select a new section from the course outline on the left side of your screen or simply click on “Next.”

 
Previous | Next Next

© Copyright 2010 Integra LifeSciences Corporation. All Rights Reserved.
Terms of Use • Privacy Policy